References
Sun H, Fu S, Cui S, Yin X, Sun X, Qi X, et al. Development of a CRISPR-SaCas9 system for projection- and function-specific gene editing in the rat brain. Sci Adv 2020, 6: eaay6687.
Liu X, Ramirez S, Pang PT, Puryear CB, Govindarajan A, Deisseroth K, et al. Optogenetic stimulation of a hippocampal engram activates fear memory recall. Nature 2012, 484: 381–385.
Yap EL, Greenberg ME. Activity-regulated transcription: bridging the gap between neural activity and behavior. Neuron 2018, 100: 330–348.
Guo YC, Yuan T, Guo BY. The secret of fear memory attenuation: facing fears. Neurosci Bull 2019, 35: 775–777.
Koya E, Golden SA, Harvey BK, Guez-Barber DH, Berkow A, Simmons DE, et al. Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization. Nat Neurosci 2009, 12: 1069–1073.
Hebb DO. The organization of behavior: a neuropsychological theory. New York: Wiley 1949.
Ryan TJ, Roy DS, Pignatelli M, Arons A, Tonegawa S. Memory. Engram cells retain memory under retrograde amnesia. Science 2015, 348: 1007–1013.
Tonegawa S, Pignatelli M, Roy DS, Ryan TJ. Memory engram storage and retrieval. Curr Opin Neurobiol 2015, 35: 101–109.
Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339: 819–823.
Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 2014, 159: 440–455.
Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154: 442–451.
Chavez A, Tuttle M, Pruitt BW, Ewen-Campen B, Chari R, Ter-Ovanesyan D, et al. Comparison of Cas9 activators in multiple species. Nat Methods 2016, 13: 563–567.
Nihongaki Y, Kawano F, Nakajima T, Sato M. Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat Biotechnol 2015, 33: 755–760.
Zetsche B, Volz SE, Zhang F. A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat Biotechnol 2015, 33: 139–142.
Davis KM, Pattanayak V, Thompson DB, Zuris JA, Liu DR. Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat Chem Biol 2015, 11: 316–318.
Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu WL, et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci 2017, 20: 1172–1179.
Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 2013, 154: 1380–1389.
Guilinger JP, Thompson DB, Liu DR. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol 2014, 32: 577–582.
Chew WL, Tabebordbar M, Cheng JK, Mali P, Wu EY, Ng AH, et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat Methods 2016, 13: 868–874.
Yang S, Li S, Li XJ. Shortening the half-life of Cas9 maintains its gene editing ability and reduces neuronal toxicity. Cell Rep 2018, 25: 2653–2659.
Acknowledgements
This insight article was supported by grants from the National Natural Science Foundation of China (81974166, 31872774, 31371119, 91732107, and 81821092), Beijing Natural Science Foundation (7202083, 5182013), the National Basic Research (973) Program of the Ministry of Science and Technology of China (2014CB548200 and 2015CB554503), and the Interdisciplinary Medicine Seed Fund of Peking University (BMU2018MX011).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, H., Zheng, J., Yi, M. et al. Conditional Genome Editing in the Mammalian Brain Using CRISPR-Cas9. Neurosci. Bull. 37, 423–426 (2021). https://doi.org/10.1007/s12264-020-00599-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12264-020-00599-z